SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-134271
Filing Date
2011-05-10
Accepted
2011-05-10 16:30:51
Documents
9
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 526166
2 EXECUTIVE EMPLOYMENT AGREEMENT dex101.htm EX-10.1 60193
3 STAND ALONE STOCK OPTION GRANT dex102.htm EX-10.2 79767
4 MODIFICATION NO. PZ0001 TO CONTRACT NUMBER HDTRA1-10-C-0079 dex103.htm EX-10.3 353430
5 EXECUTIVE EMPLOYMENT AGREEMENT dex104.htm EX-10.4 63826
6 SECTION 302 PRESIDENT AND CEO CERTIFICATION dex311.htm EX-31.1 6595
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6565
8 SECTION 906 PRESIDENT AND CEO CERTIFICATION dex321.htm EX-32.1 4282
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4266
  Complete submission text file 0001193125-11-134271.txt   1106201
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 11828614
SIC: 2834 Pharmaceutical Preparations